Assembly Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Assembly Biosciences, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026, to elect directors and vote on key corporate proposals.
NASDAQ
DEFA14A: Assembly Biosciences Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Assembly Biosciences has scheduled its 2025 Annual Meeting for June 5, 2025, and is seeking stockholder votes on director elections, executive compensation, auditor ratification, and amendments to stock incentive and purchase plans.
NASDAQ
DEF: Assembly Biosciences Seeks Stockholder Approval for Equity Plan Amendments at 2025 Annual Meeting
Assembly Biosciences is asking stockholders to approve amendments to its stock incentive and employee stock purchase plans at the 2025 Annual Meeting to increase the number of shares available for issuance.
NASDAQ
DEFA14A: Assembly Biosciences Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Assembly Biosciences has scheduled its 2024 Annual Meeting of Stockholders for May 29, 2024, and is seeking votes on director elections, executive compensation, auditor ratification, and stock plan amendments.
NASDAQ
Assembly Biosciences is asking stockholders to vote on proposals to amend its stock incentive and employee stock purchase plans at the upcoming annual meeting.